av/aptevo-therapeutics--big.svg

NASDAQ:APVO

Aptevo Therapeutics

  • Stock

USD

Last Close

1.47

06/11 22:27

Market Cap

2.78M

Beta: 5.32

Volume Today

406.93K

Avg: 60.96K

PE Ratio

0.07

PFCF: −0.27

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-51.12M
-
-59.32M
16.05%
-112.42M
89.52%
6.97M
106.20%
-53.69M
869.96%
-40.45M
24.66%
-17.75M
56.12%
-28.46M
60.32%
8.03M
128.21%
-18.65M
332.34%
depreciation and amortization
2.02M
-
2.91M
43.84%
3.36M
15.65%
3.13M
6.99%
2.39M
23.57%
2.23M
6.49%
1.41M
37.09%
1.14M
18.63%
901K
21.24%
567K
37.07%
deferred income tax
117K
-
-1.36M
1,263.25%
71.21M
5,332.40%
-2K
100.00%
-4.25M
-
-12.23M
187.86%
4K
100.03%
-518K
-
stock based compensation
1.07M
-
1.11M
3.07%
3.81M
244.08%
4.88M
28.22%
2.14M
56.18%
1.60M
25.33%
1.25M
21.46%
1.64M
30.92%
1.80M
9.68%
2.19M
21.70%
change in working capital
592K
-
4.21M
610.98%
13.83M
228.58%
-4.50M
132.51%
-3.25M
27.69%
-2.19M
32.61%
-2.41M
9.81%
-2.65M
10.35%
2.14M
180.75%
2.91M
35.77%
accounts receivables
-6.13M
-
3.88M
163.32%
1.97M
49.23%
-1.83M
193.00%
-3.08M
67.88%
-1.80M
41.47%
-2.37M
31.47%
-1.29M
45.34%
1.16M
189.88%
2.50M
114.78%
inventory
4.95M
-
-2.70M
154.44%
13.68M
607.34%
-567K
104.14%
-757K
33.51%
-4.35M
475.17%
-1.05M
75.79%
1.29M
222.87%
-1.16M
189.88%
accounts payables
820K
-
-1.67M
303.54%
2.48M
248.53%
195K
92.13%
1.28M
555.90%
-2.70M
310.87%
-702K
73.97%
-1.92M
172.79%
-394K
79.43%
518K
231.47%
other working capital
952K
-
4.69M
392.75%
-4.30M
191.75%
-2.29M
46.79%
-694K
69.69%
6.66M
1,059.94%
1.72M
74.20%
-740K
143.05%
2.54M
442.97%
-107K
104.22%
other non cash items
304K
-
3.69M
1,115.46%
-16.66M
550.91%
-52.06M
212.46%
988K
101.90%
673K
31.88%
411K
38.93%
6.64M
1,516.06%
-33.90M
610.33%
1.77M
105.21%
net cash provided by operating activities
-47.01M
-
-48.76M
3.73%
-36.86M
24.40%
-41.57M
12.78%
-51.42M
23.69%
-42.38M
17.58%
-29.32M
30.83%
-21.68M
26.06%
-21.02M
3.03%
-11.73M
44.20%
investments in property plant and equipment
-989K
-
-1.53M
54.40%
-2.51M
64.51%
-1.40M
44.19%
-976K
30.39%
-153K
84.32%
-88K
42.48%
-713K
710.23%
-29K
95.93%
acquisitions net
-47.81M
-
59.76M
-
65K
99.89%
4.25M
6,438.46%
28.12M
561.65%
purchases of investments
-44.88M
-
-99.63M
121.99%
-16.54M
83.40%
sales maturities of investments
70.73M
-
90.24M
27.59%
other investing activites
net cash used for investing activites
-48.80M
-
-1.53M
96.87%
-47.39M
3,003.73%
29.46M
162.16%
72.80M
147.12%
4.10M
94.37%
28.03M
584.21%
-713K
102.54%
-29K
95.93%
debt repayment
-602K
-
-137K
77.24%
-22.10M
16,034.31%
-10.55M
52.27%
-12.27M
16.27%
-3.47M
71.74%
common stock issued
18K
-
442K
2,355.56%
623K
40.95%
20.34M
3,165.49%
21.26M
4.49%
10.23M
51.86%
6.93M
32.24%
9.47M
36.65%
common stock repurchased
-58K
-
-11K
81.03%
10.23M
93,127.27%
-4K
100.04%
dividends paid
-58K
-
-21.25M
36,532.76%
-10.23M
51.84%
-4K
99.96%
other financing activites
99.40M
-
51.33M
48.36%
89.28M
73.92%
9.09M
89.82%
-808K
108.89%
58K
107.18%
45.98M
79,172.41%
26.48M
42.41%
2.73M
89.71%
-10K
100.37%
net cash used provided by financing activities
99.40M
-
51.33M
48.36%
89.30M
73.96%
9.53M
89.32%
-787K
108.25%
20.15M
2,660.23%
23.87M
18.49%
26.16M
9.58%
-2.62M
110.00%
6.00M
329.28%
effect of forex changes on cash
net change in cash
3.59M
-
1.04M
70.94%
5.04M
382.66%
-2.58M
151.22%
20.59M
897.68%
-18.14M
188.10%
22.59M
224.54%
3.77M
83.31%
-23.67M
727.94%
-5.73M
75.78%
cash at beginning of period
3.59M
-
4.64M
29.06%
9.68M
108.67%
17.50M
80.81%
38.08M
117.68%
19.95M
47.62%
42.53M
113.25%
46.30M
8.86%
22.64M
51.12%
cash at end of period
3.59M
-
4.64M
29.06%
9.68M
108.67%
7.09M
26.67%
38.08M
436.76%
19.95M
47.62%
42.53M
113.25%
46.30M
8.86%
22.64M
51.11%
16.90M
25.32%
operating cash flow
-47.01M
-
-48.76M
3.73%
-36.86M
24.40%
-41.57M
12.78%
-51.42M
23.69%
-42.38M
17.58%
-29.32M
30.83%
-21.68M
26.06%
-21.02M
3.03%
-11.73M
44.20%
capital expenditure
-989K
-
-1.53M
54.40%
-2.51M
64.51%
-1.40M
44.19%
-976K
30.39%
-153K
84.32%
-88K
42.48%
-713K
710.23%
-29K
95.93%
free cash flow
-48.00M
-
-50.29M
4.77%
-39.37M
21.70%
-42.98M
9.15%
-52.40M
21.93%
-42.54M
18.82%
-29.41M
30.87%
-22.39M
23.85%
-21.05M
5.99%
-11.73M
44.28%

All numbers in USD (except ratios and percentages)